Galectin Therapeutics
GALT
#8191
Rank
S$0.22 B
Marketcap
$3.66
Share price
-3.37%
Change (1 day)
40.30%
Change (1 year)

EPS for Galectin Therapeutics (GALT)

EPS in 2023 (TTM): -$0.90

According to Galectin Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.89. In 2022 the company made an earnings per share (EPS) of -$0.87 a decrease over its 2021 EPS that were of -$0.70.

EPS history for Galectin Therapeutics from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.902.61%
2022-$0.8725%
2021-$0.7030%
2020-$0.54-6.98%
2019-$0.5813.16%
2018-$0.51-22.45%
2017-$0.66-35.53%
2016-$1.02-13.64%
2015-$1.1811.39%
2014-$1.06-39.69%
2013-$1.7681.94%
2012-$0.97-32.08%
2011-$1.437.07%
2010-$1.33-17.5%
2009-$1.61150%
2008-$0.65-68%
2007-$2.02127.27%
2006-$0.89-52.17%
2005-$1.86-20.69%
2004-$2.3452.63%
2003-$1.53-13.64%
2002-$1.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$17.25 1,842.42%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.26-71.21%๐Ÿ‡บ๐Ÿ‡ธ USA